Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (6), 724-727
- https://doi.org/10.1016/0277-5379(90)90127-f
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- DNA topoisomerases and DNA repairBioEssays, 1988
- Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionChemico-Biological Interactions, 1988
- Clinical trial of etoposide and cisplatin as salvage therapy in advanced ovarian carcinomaGynecologic Oncology, 1987
- Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.Journal of Clinical Investigation, 1987
- Direct inhibition of u.v.-induced DNA excision repair in human cells by novobiocin, coumermycin and nalidixic acidCarcinogenesis: Integrative Cancer Research, 1987
- Action of etoposide (VP-16-123) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.-induced DNA damage, nor for mitochondrial hypersensitivity in ataxia telangiectasiaCarcinogenesis: Integrative Cancer Research, 1987
- Etoposide (VP‐16) plus cisplatin (DDP): A new active chemotherapeutic combination in patients with stage iii‐iv ovarian adenocarcinomaJournal of Surgical Oncology, 1986
- Evidence that novobiocin and nalidixic acid do not inhibit excision repair in u.v.-irradiated human skin fibroblasts at a pre-incision stepCarcinogenesis: Integrative Cancer Research, 1985
- ATP-dependent DNA topoisomerase from D. melanogaster reversibly catenates duplex DNA ringsCell, 1980